IMARA, Adapting SiHLE for Detained African American Adolescent Females (IMARA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00746369|
Recruitment Status : Completed
First Posted : September 4, 2008
Last Update Posted : November 19, 2013
|Condition or disease||Intervention/treatment|
|HIV Infections||Behavioral: IMARA HIV Prevention Intervention|
African American adolescent females in youth detention centers are at high risk for HIV infection. There are, however, no evidence-based interventions (EBI) for this vulnerable population. The aim of this project is to develop and test a culturally and gender-appropriate sexual health education program designed to promote HIV preventive sexual behaviors among African American adolescent females in youth detention centers. The study will be conducted in four stages: (1) adaptation of SiHLE intervention; (2) pilot adapted intervention; (3) revisions to adapted intervention, measures, and implementation; and (4) implementation and evaluation.
We will work closely with the Metro Regional Youth Detention Center (RYDC), in Atlanta, Georgia for all four stages of the project. The first stage, adaptation of SiHLE intervention, will be implemented using data collected from a prior study and with use of Community and Teen Advisory Boards (CAB and TAB). The pilot intervention will be completed with 20 participants from Metro RYDC and will test recruitment and retention strategies, the adapted intervention, and all measures. Revisions will be made based on findings from the pilot. For stage four, implementation and evaluation, we propose to recruit 350 unmarried African American adolescent females, 13-17 years of age, from Metro RYDC. While at the Metro RYDC, adolescents will be invited to participate in the proposed study. All adolescents will be required to have verbal informed parental/guardian consent and complete signed assent forms. Adolescents who are eligible and willing to participate in the project will complete an initial survey conducted on a computer(ACASI). The survey is designed to assess adolescents' sexual risk and preventive behaviors. After they complete the survey, adolescents will then be assigned, by chance alone, to receive either the adapted SiHLE intervention or the control condition. All adolescents will complete 3 individual sessions implemented by an African American health educator.
As we anticipate the participants will be released prior to the follow-up assessment, adolescents will come to a central community site to complete follow-up interviews at 3 and 6-months after completing their initial survey. We will also obtain a self-collected vaginal swab specimen to test for chlamydia and gonorrhea. We will compare the new adapted SiHLE intervention, IMARA, to the control condition in its ability to maintain or enhance adolescents' use of HIV prevention behaviors. If successful, the findings could have important implications for HIV prevention in this vulnerable population.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||188 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||IMARA, Adapting SiHLE for Detained African American Adolescent Females|
|Study Start Date :||October 2008|
|Primary Completion Date :||August 2012|
|Study Completion Date :||August 2012|
|No Intervention: 2|
IMARA HIV Prevention Intervention. Three individual sessions for incarcerated female teens.
Behavioral: IMARA HIV Prevention Intervention
Three individual sessions- behavioral intervention for incarcerated female adolescents.
- Proportion of condom protected vaginal sex acts over the last 90 days [ Time Frame: 3 and 6 months post-randomization ]
- Incident infection of chlamydia or gonorrhea as confirmed by laboratory PCR testing [ Time Frame: 3 and 6 months post-randomization ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00746369
|United States, Georgia|
|Metro Regional Youth Detention Center|
|Atlanta, Georgia, United States, 30316|
|Principal Investigator:||Ralph J. DiClemente, PhD||Emory University|